BioAffinity Technologies Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $3.62 on 03/05/24, while the lowest value for the same period was recorded at $0.95 on 09/26/23.
52-week price history of BIAF Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. BioAffinity Technologies Inc’s current trading price is -43.92% away from its 52-week high, while its distance from the 52-week low is 112.61%. The stock’s price range during the 52-week period has remained between $0.95 and $3.62. In the Healthcare sector, the company’s shares saw a trading volume of around 1.05 million for the day, which was evidently higher than the average daily volume of 0.12 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
BioAffinity Technologies Inc (BIAF) has experienced a quarterly rise of 33.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.72M and boasts a workforce of 14 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5500, with a change in price of +0.6700. Similarly, BioAffinity Technologies Inc recorded 90,679 in trading volume during the last 100 days, posting a change of +49.26%.
Examining BIAF’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BIAF stands at 0.24. Similarly, the long-term debt-to-equity ratio is also 0.18.
BIAF Stock Stochastic Average
As of today, BioAffinity Technologies Inc’s raw stochastic average for the last 50 days stands at 28.70%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 28.70%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 14.05% and 16.07%, respectively.
BIAF Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 38.05%. However, over the past six months, we’ve seen a weaker performance of 15.34%. The price of BIAF fallen by 29.30% over the last 30 days. And in the last five days, it has fallen by -13.62%.
